ADAM30 Gene - ADAM Metallopeptidase Domain 30

Comprehensive genomic and functional analysis of ADAM30, a disintegrin and metalloproteinase domain-containing protein.

Gene Information Card

Symbol ADAM30
Full Name ADAM metallopeptidase domain 30
Gene Type protein-coding
Chromosomal Location 1p12
NCBI Gene ID 11085 ncbi.nlm.nih.gov/gene/11085
Ensembl ID ENSG00000115310
UniProt ID Q9UKF2
OMIM ID 604779
HGNC ID 213
Aliases ADAM 30, ADAM30P, disintegrin and metalloproteinase domain-containing protein 30

Description

ADAM30 (ADAM metallopeptidase domain 30) is a protein-coding gene located on chromosome 1p12. It encodes a member of the ADAM (a disintegrin and metalloprotease) family, which are transmembrane proteins involved in cell adhesion, migration, proteolysis, and signaling. ADAM30 is expressed in various tissues and has been implicated in Alzheimer disease and cancer. The protein contains a metalloprotease domain, a disintegrin domain, and a cytoplasmic tail. Alternative splicing results in multiple transcript variants.

Disease Associations

Disease category Pathophysiological mechanism Genomic evidence
Alzheimer disease ADAM30 may modulate APP processing; reduced expression linked to increased amyloid-beta production PMID: 22179788
Breast cancer ADAM30 overexpression associated with poor prognosis; may promote tumor cell migration and invasion PMID: 23455478
Gastric cancer ADAM30 downregulation correlates with metastasis and worse survival PMID: 25634892

Expression Profile

Tissue Expression
Tissue nTPM level
Brain 2.3 Low
Heart 1.8 Low
Liver 0.9 Not detected
Kidney 1.5 Low
Lung 2.1 Low
Testis 4.7 Medium
Cell Line Expression
Cell Line nTPM Notes
HEK 293 3.2 Embryonic kidney cells
HeLa 2.8 Cervical cancer cells
MCF7 4.1 Breast cancer cells
A549 3.5 Lung cancer cells
SH-SY5Y 5.0 Neuroblastoma cells
Data source:Human Protein Atlas(proteinatlas.org)

Mutations & Variants

Hotspot Mutations
Variant Type Frequency Functional Description
c.157G>A (p.Gly53Arg) Missense 0.01% Unknown functional effect
c.1124C>T (p.Thr375Met) Missense 0.02% Reported in Alzheimer disease cohort
c.1852_1853del (p.Leu618Glufs*2) Frameshift Rare Predicted loss of function
Mutation functional classification

Loss of Function (LOF)

Frameshift mutations (e.g., p.Leu618Glufs*2) likely cause loss of metalloprotease activity.

Gain of Function (GOF)

No confirmed gain-of-function mutations reported.

Dominant Negative (DN)

No evidence for dominant-negative effects.

Gene Ontology (GO)

• GO:0004222 - metalloendopeptidase activity • GO:0008237 - metallopeptidase activity
• GO:0007155 - cell adhesion • GO:0005886 - plasma membrane
• GO:0016021 - integral component of membrane • GO:0006508 - proteolysis

Pathways

Alzheimer disease - amyloid-beta secretase pathway (Reactome: R-HSA-977225)
ADAM-mediated ectodomain shedding (Reactome: R-HSA-5663205)

Protein Summary

ADAM30 is a transmembrane metalloprotease with a signal peptide, prodomain, metalloprotease domain, disintegrin domain, cysteine-rich region, EGF-like domain, transmembrane domain, and cytoplasmic tail. It is involved in ectodomain shedding of cell surface proteins, cell adhesion, and migration. The protein is expressed in brain, testis, and several cancer cell lines. Dysregulation of ADAM30 has been linked to Alzheimer disease and cancer progression.

Related Products

Product name Cat.No. Species Gene ID
ADAM30 Knockout HEK293 Cell Line EDJ-KQ6651 Human 11085 Details Get a Quote
ADAM30 Knockout HeLa Cell Line EDJ-KQ55566 Human 11085 Details Get a Quote
ADAM30 Knockout A-549 Cell Line EDJ-KQ64061 Human 11085 Details Get a Quote
ADAM30 Knockout HCT 116 Cell Line EDJ-KQ72512 Human 11085 Details Get a Quote
Displaying Records 1 To 4 Of 4 Records
Contact Us
*
*
*
*
How did you hear about us: